Heron Therapeutics Inc. (HRTX)
NASDAQ: HRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 10:31 AM ET
HRTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $69.14M
- EPS (TTM)
- -$0.18
- Dividend yield
- None
- 52-week range
- 0.26 – 1.58
- Day range
- 0.36 – 0.38
- Volume / Avg
- 346.55K / 2.58M
- Beta
- —
- Shares outstanding
- 189.85M
- Next earnings
- Nov 3, 2026
52-week range
HRTX stock today
Heron Therapeutics (HRTX) is trading at $0.3642 on Oct 8, down 5.23% (-$0.0201), versus the S&P 500's 0.12% decline. At this level, HRTX sits near the bottom of its 52-week range of $0.26 to $1.58: 76.9% below the high, set on Jan 9, 2026 and 40.1% above the low. HRTX is down 70.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 70.9%.
Heron Therapeutics has posted a net loss over the last twelve months (EPS of -$0.18), so its P/E ratio is not meaningful. Heron Therapeutics's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Heron Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $-0.03
Heron Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ONCYOncolytics Biotech Inc. | 0.5702 | -4.27% | $74.77M | vs HRTX |
| VRCAVerrica Pharmaceuticals Inc. | 4.14 | 0.00% | $71.12M | vs HRTX |
| PDSBPDS Biotechnology Corporation | 1.04 | -2.35% | $75.37M | vs HRTX |
| CINGCingulate Inc. | 4.85 | -0.42% | $70.52M | vs HRTX |
| GANXGain Therapeutics Inc. | 1.61 | -3.58% | $70.27M | vs HRTX |
| OSTXOS Therapies Incorporated | 1.62 | +4.39% | $75.72M | vs HRTX |
| MAIAMAIA Biotechnology Inc. | 1.14 | -3.81% | $70.08M | vs HRTX |
| LFVNLifevantage Corporation | 6.05 | +0.74% | $76.10M | vs HRTX |
Indexes, lists and sector
Heron Therapeutics stock FAQ
What is Heron Therapeutics's stock price today?
HRTX last traded at $0.3642 as of Oct 8, 10:31 AM EDT, down 5.23% on the day. Prices are delayed at least 15 minutes.
Does Heron Therapeutics pay a dividend?
No. Heron Therapeutics does not currently pay a regular cash dividend.
When is Heron Therapeutics's next earnings date?
Heron Therapeutics is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $-0.03.
Has HRTX ever split its stock?
Yes. The most recent HRTX stock split was a 1-for-20 split on Jan 13, 2014, one of 2 splits on record.
What is the HRTX 52-week high?
The 52-week high for HRTX is $1.58 and the 52-week low is $0.26. The stock is currently 76.9% below its high.